South Korea · Delayed Price · Currency is KRW LAMEDITECH Statistics
Total Valuation
LAMEDITECH has a market cap or net worth of KRW 28.70 billion. The enterprise value is 30.57 billion.
| Market Cap | 28.70B |
| Enterprise Value | 30.57B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
LAMEDITECH has 8.80 million shares outstanding. The number of shares has increased by 4.63% in one year.
| Current Share Class | 8.80M |
| Shares Outstanding | 8.80M |
| Shares Change (YoY) | +4.63% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 30.32% |
| Owned by Institutions (%) | n/a |
| Float | 4.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.72 |
| PB Ratio | 5.01 |
| P/TBV Ratio | 5.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.66 |
| EV / Sales | 5.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.02 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.30.
| Current Ratio | 1.41 |
| Quick Ratio | 0.71 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.49 |
| Interest Coverage | -28.46 |
Financial Efficiency
Return on equity (ROE) is -102.44% and return on invested capital (ROIC) is -47.72%.
| Return on Equity (ROE) | -102.44% |
| Return on Assets (ROA) | -34.33% |
| Return on Invested Capital (ROIC) | -47.72% |
| Return on Capital Employed (ROCE) | -95.18% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.77% in the last 52 weeks. The beta is 0.27, so LAMEDITECH's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -60.77% |
| 50-Day Moving Average | 4,593.60 |
| 200-Day Moving Average | 6,071.58 |
| Relative Strength Index (RSI) | 32.69 |
| Average Volume (20 Days) | 165,754 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAMEDITECH had revenue of KRW 6.08 billion and -11.51 billion in losses. Loss per share was -1,309.42.
| Revenue | 6.08B |
| Gross Profit | 2.64B |
| Operating Income | -11.73B |
| Pretax Income | -11.51B |
| Net Income | -11.51B |
| EBITDA | -11.12B |
| EBIT | -11.73B |
| Loss Per Share | -1,309.42 |
Balance Sheet
The company has 5.58 billion in cash and 7.45 billion in debt, with a net cash position of -1.87 billion or -212.68 per share.
| Cash & Cash Equivalents | 5.58B |
| Total Debt | 7.45B |
| Net Cash | -1.87B |
| Net Cash Per Share | -212.68 |
| Equity (Book Value) | 5.73B |
| Book Value Per Share | 651.24 |
| Working Capital | 4.01B |
Cash Flow
In the last 12 months, operating cash flow was -13.05 billion and capital expenditures -2.06 billion, giving a free cash flow of -15.10 billion.
| Operating Cash Flow | -13.05B |
| Capital Expenditures | -2.06B |
| Depreciation & Amortization | 611.32M |
| Net Borrowing | 12.25B |
| Free Cash Flow | -15.10B |
| FCF Per Share | -1,715.80 |
Margins
Gross margin is 43.38%, with operating and profit margins of -193.08% and -189.34%.
| Gross Margin | 43.38% |
| Operating Margin | -193.08% |
| Pretax Margin | -189.34% |
| Profit Margin | -189.34% |
| EBITDA Margin | -183.02% |
| EBIT Margin | -193.08% |
| FCF Margin | n/a |
Dividends & Yields
LAMEDITECH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.63% |
| Shareholder Yield | -4.63% |
| Earnings Yield | -40.10% |
| FCF Yield | -52.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAMEDITECH has an Altman Z-Score of -2.16 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.16 |
| Piotroski F-Score | 1 |